Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AMP-DNA
- Development stage
- Preclinical
- Lead developer
- Elicio Therapeutics
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intramuscular
01
Overview
AMP-DNA is an investigational DNA vaccine developed using Elicio Therapeutics' proprietary Amphiphile (AMP) platform. The AMP technology involves the conjugation of a lipid tail to a DNA sequence, which allows the vaccine to bind to albumin upon injection. This binding facilitates the targeted delivery of the DNA payload directly to the lymph nodes, where immune responses are orchestrated. By concentrating the vaccine in the lymphatic system, AMP-DNA aims to enhance the activation of antigen-presenting cells and the subsequent induction of robust T cell responses compared to conventional DNA vaccines. The platform is designed to overcome the historical limitations of DNA vaccines, such as poor delivery and low immunogenicity, and is being explored for applications in oncology and infectious diseases.
- Other names
- Amphiphile-DNA vaccine
02
Targets
DNA
Beyond the preview
Go deeper on AMP-DNA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AMP-DNA.